Compare PROF & XPER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PROF | XPER |
|---|---|---|
| Founded | N/A | 1990 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.8M | 271.2M |
| IPO Year | 2017 | 2021 |
| Metric | PROF | XPER |
|---|---|---|
| Price | $7.44 | $6.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $11.14 | ★ $11.40 |
| AVG Volume (30 Days) | 184.5K | ★ 436.1K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $16,098,000.00 | ★ $448,105,000.00 |
| Revenue This Year | $61.76 | $1.90 |
| Revenue Next Year | $70.98 | $4.49 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 50.73 | N/A |
| 52 Week Low | $4.91 | $4.91 |
| 52 Week High | $8.95 | $8.75 |
| Indicator | PROF | XPER |
|---|---|---|
| Relative Strength Index (RSI) | 62.40 | 70.83 |
| Support Level | $6.38 | $5.52 |
| Resistance Level | $7.92 | $6.50 |
| Average True Range (ATR) | 0.50 | 0.25 |
| MACD | 0.13 | 0.10 |
| Stochastic Oscillator | 75.61 | 88.84 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Xperi Inc is a media and entertainment technology company. Its technologies are integrated into consumer devices, connected cars, and a variety of media platforms globally, enabling audiences to connect with entertainment content in a more intelligent, immersive, and personal way. As its audiences engage with content on the platform, the company operates a cross-screen advertising solution that enables brands to reach millions of engaged consumers across rapidly expanding digital entertainment ecosystem. It operates in one reportable business segment and group its revenue into four categories: Pay-TV, Consumer Electronics, Connected Car and Media Platform. Geographically it operates in U.S. and Canada, Asia Pacific, Europe, Middle East and Africa, and Other countries.